Table 1 Relation between intratumoral CXCR2 expression and clinical characteristics in patients with gastric cancer (n = 357)
From: The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients
Factor | Patients | CXCR2 expression | |||
|---|---|---|---|---|---|
No. | % | Low | High | P value | |
All patients | 357 | 100 | 157 | 200 | |
Age (years) | 0.250 | ||||
Mean ± SD† | 59.4 ± 11.6 | 58.6 ± 11.1 | 60.1 ± 11.9 | ||
Gender | 0.477 | ||||
Female | 107 | 30 | 44 | 63 | |
Male | 250 | 70 | 113 | 137 | |
Tumor size (cm) | 0.931 | ||||
Mean ± SD† | 3.8 ± 2.1 | 3.8 ± 2.4 | 3.8 ± 1.9 | ||
Differentiation | 0.021 | ||||
Well | 20 | 5.6 | 14 | 6 | |
Moderately | 127 | 35.6 | 60 | 67 | |
Poorly | 210 | 58.8 | 83 | 127 | |
Lauren classification | 0.910 | ||||
Intestinal | 224 | 62.7 | 98 | 126 | |
Diffuse | 133 | 37.3 | 59 | 74 | |
pT stage | <0.001 | ||||
T1 | 60 | 16.8 | 40 | 20 | |
T2 | 50 | 14.0 | 25 | 25 | |
T3 | 65 | 18.2 | 27 | 38 | |
T4 | 182 | 51.0 | 65 | 117 | |
pN stage | <0.001 | ||||
N0 | 128 | 35.8 | 72 | 56 | |
N1 | 37 | 10.4 | 21 | 16 | |
N2 | 70 | 19.6 | 24 | 46 | |
N3 | 122 | 34.2 | 40 | 82 | |
Distant metastasis | 0.735 | ||||
Absent | 349 | 97.8 | 153 | 196 | |
Present | 8 | 2.2 | 4 | 4 | |
TNM stage | 0.001 | ||||
I | 78 | 21.8 | 49 | 29 | |
II | 80 | 22.5 | 37 | 43 | |
III | 191 | 53.5 | 67 | 124 | |
IV | 8 | 2.2 | 4 | 4 | |